HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Abstract
Secreted phospholipase A(2) group X (sPLA(2)-X) has recently been identified in the airways of patients with asthma and may participate in cysteinyl leukotriene (CysLT; C(4), D(4), and E(4)) synthesis. We examined CysLT synthesis and arachidonic acid (AA) and lysophospholipid release by eosinophils mediated by recombinant human sPLA(2)-X. We found that recombinant sPLA(2)-X caused marked AA release and a rapid onset of CysLT synthesis in human eosinophils that was blocked by a selective sPLA(2)-X inhibitor. Exogenous sPLA(2)-X released lysophospholipid species that arise from phospholipids enriched in AA in eosinophils, including phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine as well as plasmenyl phosphatidylcholine and phosphatidylethanolamine. CysLT synthesis mediated by sPLA(2)-X but not AA release could be suppressed by inhibition of cPLA(2)α. Exogenous sPLA(2)-X initiated Ser(505) phosphorylation of cPLA(2)α, an intracellular Ca(2+) flux, and translocation of cPLA(2)α and 5-lipoxygenase in eosinophils. Synthesis of CysLTs in response to sPLA(2)-X or lysophosphatidylcholine was inhibited by p38 or JNK inhibitors but not by a MEK 1/2 inhibitor. A further increase in CysLT synthesis was induced by the addition of sPLA(2)-X to eosinophils under conditions of N-formyl-methionyl-leucyl-phenylalanine-mediated cPLA(2)α activation. These results indicate that sPLA(2)-X participates in AA and lysophospholipid release, resulting in CysLT synthesis in eosinophils through a mechanism involving p38 and JNK MAPK, cPLA(2)α, and 5-lipoxygenase activation and resulting in the amplification of CysLT synthesis during cPLA(2)α activation. Transactivation of eosinophils by sPLA(2)-X may be an important mechanism leading to CysLT formation in the airways of patients with asthma.
AuthorsYing Lai, Rob C Oslund, James G Bollinger, William R Henderson Jr, Luis F Santana, William A Altemeier, Michael H Gelb, Teal S Hallstrand
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 285 Issue 53 Pg. 41491-500 (Dec 31 2010) ISSN: 1083-351X [Electronic] United States
PMID20974857 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Eicosanoids
  • Leukotrienes
  • Lysophospholipids
  • Recombinant Proteins
  • cysteinyl-leukotriene
  • Serine
  • N-Formylmethionine Leucyl-Phenylalanine
  • p38 Mitogen-Activated Protein Kinases
  • Group X Phospholipases A2
  • PLA2G10 protein, human
  • Phospholipases A2
  • Cysteine
  • Calcium
Topics
  • Asthma (drug therapy)
  • Calcium (chemistry)
  • Cysteine (biosynthesis)
  • Eicosanoids (chemistry)
  • Eosinophils (enzymology, metabolism)
  • Group X Phospholipases A2 (chemistry)
  • Humans
  • Leukotrienes (biosynthesis, chemistry)
  • Lysophospholipids (chemistry)
  • N-Formylmethionine Leucyl-Phenylalanine (pharmacology)
  • Phospholipases A2 (metabolism)
  • Phosphorylation
  • Recombinant Proteins (chemistry)
  • Serine (chemistry)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: